IMU Biosciences Selects Waters to Advance Breakthrough AI Immune Mapping Platform to Transform Early Diagnosis, Monitoring, and Precision Medicine

Contributed by: Business Wire

Tags

Science

Other Science

Biotechnology

Research

Health

Artificial Intelligence

Health Technology

Technology

Waters Corporation

More Like This

PR Newswire associated0

IMU Biosciences Selects Waters to Advance Breakthrough AI Immune Mapping Platform to Transform Early Diagnosis, Monitoring, and Precision Medicine

IMU Biosciences announces oversubscribed financing round, bringing its Series A to over $53M as it accelerates its work to decode the immune system with unprecedented resolution and scale, to transform how we understand, diagnose and treat disease

PR Newswire associated0

Waters Completes Combination with BD's Biosciences & Diagnostic Solutions Businesses

IMU Biosciences Adopts Curiox's Pluto for Large-Scale UK Immune Profiling Initiative

Waters New Bioseparations Tools Accelerate and Improve Development of RNA-based Vaccines and Therapies Using LC-MS Analysis

Beckman Coulter and Fujirebio Expand Partnership to Develop Patient-friendly, Blood-based Neurodegenerative Disease Diagnostics

Fujirebio Announces Strategic Collaboration with Stanford Medicine to Advance Infectious Disease Research

Syndesis Health and InSyBio Partner in Predictive Modelling and Biomarker Discovery